172 related articles for article (PubMed ID: 11400717)
1. Predictive validity of the overvalued ideas scale: outcome in obsessive-compulsive and body dysmorphic disorders.
Neziroglu F; Stevens KP; McKay D; Yaryura-Tobias JA
Behav Res Ther; 2001 Jun; 39(6):745-56. PubMed ID: 11400717
[TBL] [Abstract][Full Text] [Related]
2. Overvalued ideation as a predictor of fluvoxamine response in patients with obsessive-compulsive disorder.
Neziroglu F; Pinto A; Yaryura-Tobias JA; McKay D
Psychiatry Res; 2004 Jan; 125(1):53-60. PubMed ID: 14967552
[TBL] [Abstract][Full Text] [Related]
3. The Overvalued Ideas Scale: development, reliability and validity in obsessive-compulsive disorder.
Neziroglu F; McKay D; Yaryura-Tobias JA; Stevens KP; Todaro J
Behav Res Ther; 1999 Sep; 37(9):881-902. PubMed ID: 10458051
[TBL] [Abstract][Full Text] [Related]
4. Cognitive dysfunctions in patients with obsessive-compulsive disorder compared to the patients with schizophrenia patients: relation to overvalued ideas.
Kitis A; Akdede BB; Alptekin K; Akvardar Y; Arkar H; Erol A; Kaya N
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):254-61. PubMed ID: 16914246
[TBL] [Abstract][Full Text] [Related]
5. Obsessions, overvalued ideas, and delusions in obsessive-compulsive disorder.
Kozak MJ; Foa EB
Behav Res Ther; 1994 Mar; 32(3):343-53. PubMed ID: 8192634
[TBL] [Abstract][Full Text] [Related]
6. A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder.
Saxena S; Winograd A; Dunkin JJ; Maidment K; Rosen R; Vapnik T; Tarlow G; Bystritsky A
J Clin Psychiatry; 2001 Jan; 62(1):67-72; quiz 73. PubMed ID: 11235937
[TBL] [Abstract][Full Text] [Related]
7. Comparison of clinical characteristics in obsessive-compulsive disorder and body dysmorphic disorder.
McKay D; Neziroglu F; Yaryura-Tobias JA
J Anxiety Disord; 1997; 11(4):447-54. PubMed ID: 9276787
[TBL] [Abstract][Full Text] [Related]
8. Myth of the pure obsessional type in obsessive--compulsive disorder.
Williams MT; Farris SG; Turkheimer E; Pinto A; Ozanick K; Franklin ME; Liebowitz M; Simpson HB; Foa EB
Depress Anxiety; 2011 Jun; 28(6):495-500. PubMed ID: 21509914
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy.
Alonso P; Menchon JM; Pifarre J; Mataix-Cols D; Torres L; Salgado P; Vallejo J
J Clin Psychiatry; 2001 Jul; 62(7):535-40. PubMed ID: 11488364
[TBL] [Abstract][Full Text] [Related]
10. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L
Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
[TBL] [Abstract][Full Text] [Related]
11. Clinical picture of obsessive-compulsive disorder with poor insight: a regression model.
Bellino S; Patria L; Ziero S; Bogetto F
Psychiatry Res; 2005 Sep; 136(2-3):223-31. PubMed ID: 16125785
[TBL] [Abstract][Full Text] [Related]
12. Clinical subtypes of obsessive-compulsive disorder based on the presence of checking and washing compulsions.
Fontenelle LF; Mendlowicz MV; Versiani M
Braz J Psychiatry; 2005 Sep; 27(3):201-7. PubMed ID: 16224607
[TBL] [Abstract][Full Text] [Related]
13. Status of body dysmorphic disorder in Argentina.
Borda T; Neziroglu F; Santos N; Donnelly K; Rivera RP
J Anxiety Disord; 2011 May; 25(4):507-12. PubMed ID: 21257286
[TBL] [Abstract][Full Text] [Related]
14. The Brief Obsessive-Compulsive Scale (BOCS): a self-report scale for OCD and obsessive-compulsive related disorders.
Bejerot S; Edman G; Anckarsäter H; Berglund G; Gillberg C; Hofvander B; Humble MB; Mörtberg E; Råstam M; Ståhlberg O; Frisén L
Nord J Psychiatry; 2014 Nov; 68(8):549-59. PubMed ID: 24568661
[TBL] [Abstract][Full Text] [Related]
15. Effects of selective serotonin reuptake inhibitors on thought-action fusion, metacognitions, and thought suppression in obsessive-compulsive disorder.
Besiroglu L; Çetinkaya N; Selvi Y; Atli A
Compr Psychiatry; 2011; 52(5):556-61. PubMed ID: 21109243
[TBL] [Abstract][Full Text] [Related]
16. Insight in body dysmorphic disorder with and without comorbid obsessive-compulsive disorder.
Marazziti D; Giannotti D; Catena MC; Carlini M; Dell'Osso B; Presta S; Pfanner C; Mungai F; Dell'Osso L
CNS Spectr; 2006 Jul; 11(7):494-8. PubMed ID: 16816788
[TBL] [Abstract][Full Text] [Related]
17. Body dysmorphic disorder, pathological gambling, and sexual compulsions.
Hollander E; Wong CM
J Clin Psychiatry; 1995; 56 Suppl 4():7-12; discussion 13. PubMed ID: 7713866
[TBL] [Abstract][Full Text] [Related]
18. Level of insight and clinical features of obsessive-compulsive disorder with and without body dysmorphic disorder.
Nakata AC; Diniz JB; Torres AR; de Mathis MA; Fossaluza V; Bragancas CA; Ferrão Y; Miguel EC
CNS Spectr; 2007 Apr; 12(4):295-303. PubMed ID: 17426667
[TBL] [Abstract][Full Text] [Related]
19. Quetiapine augmentation of serotonin reuptake inhibitors in treatment-refractory obsessive-compulsive disorder: is response to treatment predictable?
Carey PD; Lochner C; Kidd M; Van Ameringen M; Stein DJ; Denys D
Int Clin Psychopharmacol; 2012 Nov; 27(6):321-5. PubMed ID: 22859064
[TBL] [Abstract][Full Text] [Related]
20. Initial data on a 5-item measure of OCD symptom severity and change: The obsessive compulsive session change index (OCSCI).
Collins LM; Coles ME
J Anxiety Disord; 2016 Oct; 43():8-13. PubMed ID: 27467028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
